This inventor holds 1 USPTO granted patent. Top assignees: Beijing University of Technology, Melbourne Health. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 389 
1 out of 24 Years Active: 2022
Title: Leon Caly: Innovator in Viral Inhibition
Introduction
Leon Caly is an accomplished inventor based in Melbourne, Australia. He has made significant contributions to the field of viral inhibition, particularly in relation to coronaviruses. His innovative approach utilizes macrocyclic lactones to combat viral infections.
Latest Patents
Leon Caly holds a patent related to viral inhibition. The technology involves the use of at least one macrocyclic lactone, such as ivermectin or moxidectin, to inhibit a coronavirus in a subject. This invention aims to treat, prevent, or reduce the risk of infection by the coronavirus.
Career Highlights
Throughout his career, Leon has worked with notable institutions, including Melbourne Health and Beijing University of Technology. His work has been pivotal in advancing research in viral treatments and has garnered attention in the scientific community.
Collaborations
Leon has collaborated with esteemed colleagues, including David Andrew Jans and Kylie Michelle Wagstaff. Their combined expertise has contributed to the development of innovative solutions in the field of viral research.
Conclusion
Leon Caly is a prominent figure in the realm of viral inhibition, with a focus on utilizing macrocyclic lactones to address coronavirus infections. His contributions to science and collaboration with other experts highlight his commitment to advancing medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile